Related Experiment Videos
A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
Yuan Yang1, Linghao Zhao1, Bo Huang2
1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Abstract:
Hypermethylation of CpG islands in the promoter region of tumor suppressor genes (TSGs) and their subsequent silencing is thought to be one of the main mechanisms of carcinogenesis. MBD2b enrichment coupled with a NimbleGen array was applied to examine the genome-wide CpG island methylation profile of hepatocellular carcinoma (HCC). Hypermethylated DNA of 58 pairs of HCC and adjacent tissue samples was enriched and hybridized in the same array. Aberrant hypermethylated peaks of HCC and adjacent tissues were screened and annotated after data processing using NimbleScan2.5 and our newly developed Weighting and Scoring (WAS) method, respectively. Validation using bisulfite sequencing of randomly selected ANKRD45, APC, CDX1, HOXD3, PTGER and TUBB6 genes demonstrated significant hypermethylation modification in HCC samples, consistent with the array data.
Insights
CpG island hypermethylation in tumor suppressor genes (TSGs) is key in cancer. This study profiled hepatocellular carcinoma (HCC) epigenomes, identifying aberrant methylation patterns linked to cancer development.
Area of Science:
- Epigenetics
- Cancer Biology
- Genomics
Background:
- CpG island hypermethylation and gene silencing are critical in carcinogenesis.
- Tumor suppressor genes (TSGs) are frequently affected by aberrant methylation.
- Hepatocellular carcinoma (HCC) is a major global health concern with complex molecular underpinnings.
Purpose of the Study:
- To investigate the genome-wide CpG island methylation profile in hepatocellular carcinoma (HCC).
- To identify aberrant hypermethylation patterns associated with HCC development.
- To validate findings in clinical HCC samples.
Main Methods:
- Utilized MBD2b enrichment and NimbleGen arrays for genome-wide methylation profiling.
- Analyzed 58 pairs of HCC and adjacent tissue samples.
- Employed NimbleScan2.5 and a novel Weighting and Scoring (WAS) method for data analysis.
- Validated array data using bisulfite sequencing for specific genes.
Main Results:
- Identified genome-wide aberrant CpG island hypermethylation in HCC tissues compared to adjacent tissues.
- Screened and annotated hypermethylated peaks using advanced bioinformatics tools.
- Confirmed significant hypermethylation in key genes (e.g., ANKRD45, APC, CDX1) in HCC samples via bisulfite sequencing.
Conclusions:
- Aberrant CpG island hypermethylation is a significant epigenetic alteration in hepatocellular carcinoma.
- The identified methylation patterns provide insights into HCC pathogenesis.
- This study establishes a comprehensive methylation profile for HCC, aiding future biomarker discovery.